Recent News

• 02.09.2026 - Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai
• 02.05.2026 - Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument
• 02.04.2026 - Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform
• 12.30.2025 - Co-Diagnostics Announces Reverse Stock Split
• 12.29.2025 - Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies
• 12.18.2025 - Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India
• 12.08.2025 - Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Recent Filings

• 01.21.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 01.13.2026 - 8-K Current report
• 12.30.2025 - EX-99.1 EX-99.1
• 12.30.2025 - 8-K Current report
• 12.19.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 12.05.2025 - 8-K Current report
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities